We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+2.83%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.76B
AUM Growth
+$499M
Cap. Flow
+$366M
Cap. Flow %
4.71%
Top 10 Hldgs %
15.72%
Holding
1,667
New
74
Increased
571
Reduced
929
Closed
86

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$48.8M
2
DOC icon
Healthpeak Properties
DOC
+$16.2M
3
CLX icon
Clorox
CLX
+$16.1M
4
BF.B icon
Brown-Forman Class B
BF.B
+$14.4M
5
HRL icon
Hormel Foods
HRL
+$14.3M

Sector Composition

Rank Sector Weight
1 Healthcare 16.62%
2 Technology 13.27%
3 Financials 13.22%
4 Consumer Staples 11.59%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAT icon
1476
Nordic American Tanker
NAT
$1.28B
$148K ﹤0.01%
10,706
-298
-3% -$4.34K
KND
1477
DELISTED
Kindred Healthcare
KND
$147K ﹤0.01%
12,980
+350
+3% +$4.38K
CLF icon
1478
Cleveland-Cliffs
CLF
$5.29B
$145K ﹤0.01%
25,529
+4,148
+19% +$17.1K
EXAS
1479
DELISTED
Exact Sciences
EXAS
$145K ﹤0.01%
11,843
+103
+0.9% +$776
FOMX
1480
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$145K ﹤0.01%
22,818
-2,405
-10% -$16K
DRRX
1481
DELISTED
DURECT Corp
DRRX
$144K ﹤0.01%
11,769
+1,537
+15% +$19.7K
SCS
1482
DELISTED
Steelcase
SCS
$143K ﹤0.01%
10,531
+336
+3% +$5.09K
OSIR
1483
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$143K ﹤0.01%
28,080
+434
+2% +$2.34K
KRNY icon
1484
Kearny Financial
KRNY
$598M
$142K ﹤0.01%
11,287
-162
-1% -$2.08K
CALY
1485
Callaway Golf Company
CALY
$3.48B
$139K ﹤0.01%
13,636
+1,934
+17% +$18.6K
GPRO icon
1486
GoPro
GPRO
$114M
$138K ﹤0.01%
+12,803
New +$142K
LRMR icon
1487
Larimar Therapeutics
LRMR
$384M
$138K ﹤0.01%
1,925
+90
+5% +$7.11K
QURE icon
1488
uniQure
QURE
$2.77B
$136K ﹤0.01%
18,479
+1,666
+10% +$19.9K
FOE
1489
DELISTED
Ferro Corporation
FOE
$136K ﹤0.01%
+10,181
New +$135K
TTPH
1490
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$136K ﹤0.01%
1,585
+19
+1% +$1.74K
ACCO icon
1491
Acco Brands
ACCO
$376M
$134K ﹤0.01%
13,005
-450
-3% -$4.36K
CMO
1492
DELISTED
Capstead Mortgage Corp.
CMO
$134K ﹤0.01%
13,835
-90
-0.6% -$877
IMDZ
1493
DELISTED
Immune Design Corp.
IMDZ
$134K ﹤0.01%
16,372
+185
+1% +$2.31K
CRC
1494
DELISTED
California Resources Corporation
CRC
$129K ﹤0.01%
10,581
+4,982
+89% +$79.2K
RGLS
1495
DELISTED
Regulus Therapeutics
RGLS
$127K ﹤0.01%
367
+13
+4% +$9.31K
NEOS
1496
DELISTED
Neos Therapeutics, Inc
NEOS
$126K ﹤0.01%
13,622
+1,233
+10% +$11.8K
ETSY icon
1497
Etsy
ETSY
$7.98B
$123K ﹤0.01%
+12,844
New +$115K
FCF icon
1498
First Commonwealth Financial
FCF
$2.15B
$123K ﹤0.01%
13,418
-587
-4% -$5.3K
BLDR icon
1499
Builders FirstSource
BLDR
$7.99B
$122K ﹤0.01%
+10,813
New +$125K
NWS icon
1500
News Corp Class B
NWS
$17.6B
$122K ﹤0.01%
10,451
-858
-8% -$10.7K

Similar funds

ProShare Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, ProShare Advisors held 1,667 positions worth $7.76B, up 6.9% from $7.26B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

ProShare Advisors deployed $366M of net new capital in Q2 2016, opening 74 new positions and adding to 571 existing holdings. Its largest new stake was S&P Global: 454,450 shares worth $48.7M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Apple, an estimated $10.8M trimmed.

  • ProShare Advisors's largest Q2 2016 buy was S&P Global: 454,450 shares worth $48.7M.
  • ProShare Advisors added most to Healthpeak Properties in Q2 2016, an estimated $16.2M increase.
  • ProShare Advisors's biggest Q2 2016 reduction was Apple, cutting an estimated $10.8M.
  • ProShare Advisors fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $36.9M.
  • ProShare Advisors's ten largest holdings make up 16% of its $7.76B portfolio in Q2 2016.
  • ProShare Advisors opened 74 new positions and closed 86 in Q2 2016.
  • ProShare Advisors's portfolio value rose 6.9% quarter-over-quarter to $7.76B.

Based on ProShare Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.